Patterns of deregulation of insulin growth factor signalling pathway in paediatric and adult gastrointestinal stromal tumours

European Journal of Cancer

Volumn 48, Issue 17, 2012, Pages 3215-3222

  Italiano, Antoine ^a,b   Chen, Junwei ^a   Zhang, Lei ^a   Hajdu, Mihai ^a   Singer, Samuel ^a   Dematteo, Ronald P ^a   Antonescu, Cristina R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b INSTITUT BERGONIÉ   (France)

Author keywords

Gastrointestinal stromal tumour; GIST; IGF1R; IGF2

Indexed keywords

IMATINIB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; SOMATOMEDIN B;

ADULT; ARTICLE; CANCER RESISTANCE; CHILD; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SOFT TISSUE SARCOMA;

ADULT; AGE FACTORS; AGE OF ONSET; CHILD; DNA METHYLATION; FEMALE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MALE; MUTATION; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84868200205     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.05.021     Document Type: Article

References (48)

1. S. Hirota, K. Isozaki, and Y. Moriyama Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors Science 279 1998 577 580
2. M.C. Heinrich, C.L. Corless, and A. Duensing PDGFRA activating mutations in gastrointestinal stromal tumors Science 299 2003 708 710
3. A.G. GSTM Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients J Clin Oncol 28 2010 1247 1253
4. B. Liegl, I. Kepten, and C. Le Heterogeneity of kinase inhibitor resistance mechanisms in GIST J Pathol 216 2008 64 74
5. E. Hernando, E. Charytonowicz, and M.E. Dudas The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas Nat Med 13 2007 748 753
6. N.P. Agaram, M.P. Laquaglia, and B. Ustun Molecular characterization of pediatric gastrointestinal stromal tumors Clin Cancer Res 14 2008 3204 3215
7. C. Braconi, R. Bracci, and I. Bearzi Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients Ann Oncol 19 2008 1293 1298
8. C. Tarn, L. Rink, and E. Merkel Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors Proc Natl Acad Sci U S A 105 2008 8387 8392
9. M.A. Pantaleo, A. Astolfi, and M. Di Battista Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target Int J Cancer 125 2009 2991 2994
10. S.E. Steigen, D.F. Schaeffer, R.B. West, and T.O. Nielsen Expression of insulin-like growth factor 2 in mesenchymal neoplasms Mod Pathol 22 2009 914 921
11. K.A. Janeway, M.J. Zhu, J. Barretina, A. Perez-Atayde, G.D. Demetri, and J.A. Fletcher Strong expression of IGF1R in pediatric gastrointestinal stromal tumors without IGF1R genomic amplification Int J Cancer 127 2010 2718 2722
12. M. Pollak Insulin and insulin-like growth factor signalling in neoplasia Nat Rev Cancer 8 2008 915 928
13. D. Pink, D. Schoeler, and T. Lindner Severe hypoglycemia caused by paraneoplastic production of IGF-II in patients with advanced gastrointestinal stromal tumors: a report of two cases J Clin Oncol 23 2005 6809 6811
14. B. Rikhof, G. Van Den Berg, and W.T. Van Der Graaf Non-islet cell tumour hypoglycaemia in a patient with a gastrointestinal stromal tumour Acta Oncol 44 2005 764 766
15. I. Fukuda, N. Hizuka, and Y. Ishikawa Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia Growth Horm IGF Res 16 2006 211 216
16. J. Guiteau, M. Fanucchi, and A. Folpe Hypoglycemia in the setting of advanced gastrointestinal stromal tumor Am Surg 72 2006 1225 1230
17. P. Hamberg, F.A. de Jong, J.G. Boonstra, J. van Doorn, J. Verweij, and S. Sleijfer Non-islet-cell tumor induced hypoglycemia in patients with advanced gastrointestinal stromal tumor possibly worsened by imatinib J Clin Oncol 24 2006 e30 e31
18. G.A. Escobar, W.A. Robinson, and T.L. Nydam Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation: a case report BMC Cancer 7 2007 13
19. J. Zapf Insulin-like growth factor binding proteins and tumor hypoglycemia Trends Endocrinol Metab 6 1995 37 42
20. H. Zafar, C.H. Takimoto, and G. Weiss Doege-Potter syndrome: hypoglycemia associated with malignant solitary fibrous tumor Med Oncol 20 2003 403 408
21. W. Chao, and P.A. D'Amore IGF2: epigenetic regulation and role in development and disease Cytokine Growth Factor Rev 19 2008 111 120
22. M. Hajdu, S. Singer, R.G. Maki, G.K. Schwartz, M.L. Keohan, and C.R. Antonescu IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting J Pathol 221 2010 300 307
23. M.B. Leick, C.M. Shoff, E.C. Wang, J.L. Congress, and G.I. Gallicano Loss of imprinting of IGF2 and the epigenetic progenitor model of cancer Am J Stem Cell 1 2012 59 74
24. C.R. Antonescu, G. Sommer, and L. Sarran Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors Clin Cancer Res 9 2003 3329 3337
25. H. Choi, C. Charnsangavej, and S.C. Faria Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria J Clin Oncol 25 2007 1753 1759
26. C.R. Antonescu, A. Viale, and L. Sarran Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site Clin Cancer Res 10 2004 3282 3290
27. C.R. Antonescu, L. Zhang, and N.E. Chang EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene Genes Chromosomes Cancer 49 2010 1114 1124
28. D. Gordon, C. Abajian, and P Green Consed: a graphical tool for sequence finishing Genome Res 8 1998 195 202
29. D.A. Nickerson, V.O. Tobe, and S.L. Taylor PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing Nucleic Acids Res 25 1997 2745 2751
30. Chen LL, Zhu J, Prieto VG, Velasco MA, et al. Gastrointestinal Cancers Symposium. KIT signal induces membrane-bound endothelin 3 suggestive of a paracrine regulatory role of KIT and endothelin 3 in coordination of ICC and myenteric plexus ganglions in GI peristalsis. 2007; Gastrointestinal Cancers Symposium (abstract 413)
31. J.L. Martin, K.E. Willetts, and R.C. Baxter Purification and properties of a novel insulin-like growth factor-II binding protein from transformed human fibroblasts J Biol Chem 265 1990 4124 4130
32. L.A. Bach Insulin-like growth factor binding protein-6: the "forgotten" binding protein? Horm Metab Res 31 1999 226 234
33. N. Sueoka, H.Y. Lee, and S. Wiehle Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells Oncogene 19 2000 4432 4436
34. S.L. Leng, K.S. Leeding, R.H. Whitehead, and L.A. Bach Insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced but not basal proliferation and adhesion of LIM 1215 colon cancer cells Mol Cell Endocrinol 174 2001 121 127
35. H. Koike, K. Ito, Y. Takezawa, T. Oyama, H. Yamanaka, and K. Suzuki Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer Br J Cancer 92 2005 1538 1544
36. P. Grellier, B. De Galle, and S. Babajko Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth Cancer Res 58 1998 1670 1676
37. M.A. Gallicchio, M. Kneen, C. Hall, A.M. Scott, and L.A. Bach Overexpression of insulin-like growth factor binding protein-6 inhibits rhabdomyosarcoma growth in vivo Int J Cancer 94 2001 645 651
38. R. Yao, Y. Wang, R.A. Lubet, and M. You Differentially expressed genes associated with mouse lung tumor progression Oncogene 21 2002 5814 5821
39. W. Reik, M. Constancia, and W. Dean Ig/2 imprinting in development and disease Chromosomes today 13 2000 93
40. H.K. Sasaki, K. Ishihara, and R. Kato Mechanisms of Igf2/H19 imprinting: DNA methylation, chromatin and long-distance gene regulation Journal of Biochemistry 127 2000 711
41. K.L. Arney H19 and Igf2-enhancing the confusion? Trends in Genetics 19 2003 17 23
42. N. Engel, and M.S. Bartolomei Mechanisms of insulator function in gene regulation and genomic imprinting International review of cytology 232 2003 89 127
43. A. Murrell, S. Heeson, and W. Reik Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops Nature genetics 36 2004 889 893
44. A.C. Bell, and G. Felsenfeld Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene Nature 405 2000 482 485
45. A.T. Hark, C.J. Schoenherr, D.J. Katz, R.S. Ingram, J.M. Levorse, and S.M. Tilghman CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus Nature 405 2000 486 489
46. C. Kanduri, V. Pant, and D. Loukinov Functional association of CTCF with the insulator upstream of the H19 gene is parent of origin-specific and methylation-sensitive Current Biology 10 2000 853 856
47. H.M. Byun, H.L. Wong, E.A. Birnstein, E.M. Wolff, G. Liang, and A.S. Yang Examination of IGF2 and H19 loss of imprinting in bladder cancer Cancer Res 67 2007 10753 10758
48. J.J. Dupart, J.C. Trent, and H.Y. Lee Insulin-like growth factor binding protein-3 has dual effects on gastrointestinal stromal tumor cell viability and sensitivity to the anti-tumor effects of imatinib mesylate in vitro Mol Cancer 8 2009 99